Substitution of Amino Acids 1 and 3 in Teicoplanin Aglycon: Synthesis and Antibacterial Activity of Three First Non-natural Dalbaheptides.
作者:ADRIANO MALABARBA、ROMEO CIABATTI、ERMINIO GERLI、FRANCA RIPAMONTI、PIETRO FERRARI、LUIGI COLOMBO、EUGENIA N. OLSUFYEVA、ANDREY Y. PAVLOV、MARINA I. REZNIKOVA、EDUARD I. LAZHKO、MARIA N. PREOBRAZHENSKAYA
DOI:10.7164/antibiotics.50.70
日期:——
t staphylococci. As a preliminary approach, the substitution of amino acid 1 of deglucoteicoplanin (TD) with D-lysine or D-methylleucine and of its amino acid 3 with L-phenylalanine or L-lysine was investigated. In this paper, the synthesis and in vitro antibacterial activities of first non-natural dalbaheptide methyl ester aglycons MDL 63,166 (D-Lys1-Phe-3-TD-DHP-Me), MDL 64,945 (D-Lys1-Lys3-TD-DHP-Me)
用新氨基酸或其他适合与耐糖肽(D-Ala-D-乳酸)和易感(D-Ala-D-Ala)相互作用的其他化学实体替换糖肽抗生素(dalbaheptides)的氨基酸1和3靶标是目前遵循的化学策略之一,以追求对高度糖肽耐药的VanA肠球菌的活性,同时保持对糖肽敏感的革兰氏阳性细菌(特别是耐甲氧西林的葡萄球菌)的活性。作为一种初步方法,研究了用D-赖氨酸或D-甲基亮氨酸取代去葡糖二十碳素(TD)的氨基酸1及其被L-苯丙氨酸或L-赖氨酸取代的氨基酸3。本文研究了首个非天然达巴肽甲基酯糖苷配基MDL 63,166(D-Lys1-Phe-3-TD-DHP-Me)的合成和体外抗菌活性,描述了MDL 64,945(D-Lys1-Lys3-TD-DHP-Me)和MDL 64,468(D-MeLeu1-Lys3-TD-DHP-Me)。这些化合物根据9步的总体操作步骤从中间体TD衍生的四肽甲酯(TDTP-Me)获得